First molecular detection and characterization of Enterocytozoon bieneusi different genotypes in human patients from Italy.

Enterocytozoon bieneusi Gastrointestinal parasites Genotypes A, C, K Microsporidia

Journal

Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374

Informations de publication

Date de publication:
29 Jan 2024
Historique:
received: 23 11 2023
revised: 25 01 2024
accepted: 28 01 2024
medline: 4 2 2024
pubmed: 4 2 2024
entrez: 31 1 2024
Statut: aheadofprint

Résumé

Enterocytozoon bieneusi is one of the 17 microsporidian species pathogenic to humans in low and high-income countries, inducing both symptomatic and asymptomatic intestinal infections, independently of the immunological condition of the infected individual. Faecal-oral transmission occurs in a broad hosts range, including several animal species, but the parasite's zoonotic potential remains still unclear. Few studies are available in Italy regarding E. bieneusi presence in humans and no data on its genetic variability are so far reported. In this investigation, through the ITSr RNA sequences analysis, we provided the first E. bieneusi molecular characterization from symptomatic patients in Italy. Faecal samples from 410 patients sent for routine analyses to the Unit of Parasitology, Policlinico Tor Vergata, Rome, and resulted positive for E. bieneusi to a cartridge-based molecular test for qualitative detection (Novodiag® Stool Parasites assay), were collected. DNA was extracted, endpoint PCR performed and then sequences obtained for 3/410 patients (0.7 %). Genotype A (N = 1), genotype C (N = 1) and genotype K (N = 1) were identified, all belonging to phylogenetic Group 1. One patient (identified as genotype A) showed positivity to the same genotype previously characterized after a two-month period. Additional investigations are required, within a One Health framework, to review the importance of a zoonotic potential linked to E. bieneusi in human populations, animals and environmental reservoirs worldwide.

Identifiants

pubmed: 38296015
pii: S0001-706X(24)00020-2
doi: 10.1016/j.actatropica.2024.107136
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107136

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The Authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Isabel Guadano-Procesi (I)

Department of Clinical Sciences and Translational Medicine, University of "Tor Vergata", Rome 00133, Italy.

Federica Berrilli (F)

Department of Clinical Sciences and Translational Medicine, University of "Tor Vergata", Rome 00133, Italy. Electronic address: berrilli@uniroma2.it.

David Di Cave (DD)

Department of Clinical Sciences and Translational Medicine, University of "Tor Vergata", Rome 00133, Italy.

Classifications MeSH